A point-of-care assay for genotyping women prior to ovarian stimulation with recombinant or human menopausal gonadotropins in assisted reproduction | Synapse
March 3, 2026Open Access
A point-of-care assay for genotyping women prior to ovarian stimulation with recombinant or human menopausal gonadotropins in assisted reproduction
Key Points
Genotyping of FSHR N680S using a rapid LAMP assay enables informed treatment decisions.
The LAMP assay provides results quickly, streamlining processes in reproductive healthcare settings.
Assessment using a user-friendly LAMP assay indicates improved outcomes for women undergoing IVF.
This innovation highlights the potential for personalized reproductive treatment plans in clinical practice.
Abstract
The LAMP assay provides a rapid and user-friendly genotyping of the FSHR N680S, which makes it a valuable tool in point-of-care settings, where it may help guide treatment options prior to IVF.